Armata Pharmaceuticals, Inc.

US$3.51As of Sun 8 Nov 2026, 12:00 UTC
AMEX:ARMPHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 1.29%
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.64
PE TTM —
TSR TTM (28.51%)
Mkt cap US$130.5M
ROIC (28.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.75
6.96%
(31.45%)
Hold 2|1|4|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.07
0.07
17.70%
21.62%
26.14%
40.04%
Revenue$M
13.63
14.11
14.08
14.74
6.33%
6.84%
4.11%
9.83%
Peers (US$130.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.168
0.317
0.328
EBIT/Intx
0.134
0.052
0.052
Own earn%
83.67
(3.93)
(7.46)
Sh yield%
48.67
62.66
62.15
Owners
Insiders/Inst%
6.61
27.39
Short interest%
5.56
SBC / revenue%
4.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
26–30
$1 testx
0.1
Incr. ROIC%
0